Product Image

Omega Blood Sugar

Nordic Naturals
4.7
★ ★ ★ ★ ★
(826 ratings)
Chromium 200 mcg
Omega-3 896 mg
Product Image
Score74
A focused metabolic formula with useful chromium and alpha-lipoic acid doses. Omega-3 disclosure is incomplete, and glucose-lowering medication users need product-specific caution.
How scoring works
Quantity:60 Softgel(s) • (30 servings)
Goals:
Metabolism Boost
Weight Loss
Skin Health

Score 74

A focused metabolic formula with useful chromium and alpha-lipoic acid doses. Omega-3 disclosure is incomplete, and glucose-lowering medication users need product-specific caution.
How scoring works
$20.49($0.68 per serving)
Daily Vita
$ 24.61
Pure Formulas
$ 24.61
Walmart
$ 21.55
iHerb
$ 22.91
Amazon
$ 20.49
Vitacost
$ 25.87
Report prices

Analysis

The formula pairs 200 mcg of chromium nicotinate glycinate with 300 mg of alpha-lipoic acid. Both are clearly quantified and align more strongly with glucose handling and metabolism than with direct fat loss.

Total omega-3 reaches 896 mg, but EPA, DHA, source, and molecular form are not disclosed. That omission makes its cardiovascular and skin-related contribution difficult to judge precisely.

The two-softgel serving is practical and the ingredients work together without unnecessary complexity. People using insulin or sulfonylureas need closer glucose monitoring because chromium and alpha-lipoic acid may add to their effects.

Who is it for
  • Adults seeking nutritional support for glucose metabolism
  • People who value chromium paired with alpha-lipoic acid
  • Users who do not require fully disclosed EPA and DHA amounts
Best for
  • Metabolic and glucose-handling support
  • A coherent chromium and alpha-lipoic acid pairing
  • Users wanting omega-3 as a secondary active

Pros

  • Uses chromium nicotinate glycinate
  • Provides 300 mg of alpha-lipoic acid
  • Includes a substantial total omega-3 amount

Cons

  • EPA and DHA are not separately disclosed
  • Omega-3 source and molecular form are missing
  • Direct weight-loss support remains limited

Warnings

  • Chromium and alpha-lipoic acid may add to insulin or sulfonylurea effects and increase low-blood-sugar risk; medication users need clinically guided monitoring.

Nutrient quality

87 Highest impact

Meaningful amounts and a well-regarded chromium form create a focused metabolic formula. Unspecified omega-3 fractions and alpha-lipoic-acid form limit quality detail.

Ingredient transparency

63 Moderate impact

The three main active totals and implied serving size are visible. Missing fatty-acid detail, directions, and non-active ingredients reduce clarity.

Customer satisfaction

71 High impact

The aggregate rating is favorable and backed by a substantial review volume. No specific comments are available to assess recurring problems or real-world fit.

Value for money

78 High impact

Meaningful core doses provide fair formula value. Incomplete omega-3 detail limits comparison with stronger alternatives.

Report analysis

Goals

Metabolism Boost
Impact
Highest effect
A- Goal FitA Strength of SupportB CoverageA Formula Quality
Omega-3 · 896 mg

Chromium and alpha-lipoic acid provide targeted support for insulin sensitivity and glucose handling. Omega-3 adds cardiometabolic context, although its EPA and DHA amounts are not disclosed.

The chromium form and both glycemic actives are clearly quantified at practical amounts. Chromium and alpha-lipoic acid may lower blood glucose, so people using insulin or sulfonylureas should monitor for low blood sugar with clinical guidance.

Study evidence
Chromium Supportive 47 studies
Omega-3 Supportive 42 studies
Weight Loss
Impact
High effect
C Goal FitA Strength of SupportC+ CoverageA+ Formula Quality

Chromium and alpha-lipoic acid provide a coherent glucose-metabolism pairing, while omega-3 fats add broader metabolic support. All three actives are clearly measured at meaningful amounts.

Evidence for direct weight loss remains limited, and the formula has no satiety, protein, or thermogenic ingredient. Chromium and alpha-lipoic acid may lower blood glucose, so insulin or sulfonylurea users need monitoring for low blood sugar.

Study evidence
Chromium No effect 24 studies
Skin Health
Impact
Moderate effect
C+ Goal FitC Strength of SupportC CoverageD+ Formula Quality
Omega-3 · 896 mg

Omega-3 fats and alpha-lipoic acid offer barrier and antioxidant relevance, though the formula is built for glucose support. Alpha-lipoic acid has antioxidant evidence, but the full formula lacks direct human trials for skin outcomes.

The 896 mg total omega-3 amount is moderate, but active EPA and DHA amounts are not separated. Chromium and alpha-lipoic acid may add to glucose-lowering medicines and warrant closer glucose monitoring.

Study evidence
Omega-3 Supportive 35 studies

Ingredients

IngredientAmount per serving
Calories
15 Calorie(s)
Total Fat
1.5 Gram(s)
Chromium (Chromium Nicotinate Glycinate)
200 mcg
Alpha-Lipoic Acid
300 mg
Total Omega-3 Fatty Acids
896 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
B- Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyB Value

Chromium nicotinate glycinate offers a bioavailable 200 mcg dose supported by 300 mg of alpha-lipoic acid. The companion active improves the formula's value despite a higher chromium-specific cost. Chromium and alpha-lipoic acid may both lower blood glucose, so people using insulin or sulfonylureas should monitor for low blood sugar with clinical guidance.

Omega-3 · 896 mg OverallScore24
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyF Value

The formula provides 896 mg of total omega-3 without disclosing separate EPA and DHA amounts. Missing form, source, antioxidant, and purity details limit confidence in quality and value. Chromium and alpha-lipoic acid may lower blood glucose, so people using glucose-lowering medicines may need closer monitoring.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease.
    Farrokhian A; Mahmoodian M; Bahmani F; Amirani E; Shafabakhsh R; Asemi Z · Biological trace element research · 2021
    Randomized trial64 participantsWeight Loss forChromium
  2. Association Between Essential and Non-essential Metals, Body Composition, and Metabolic Syndrome in Adults.
    Ngu YJ; Skalny AV; Tinkov AA; Tsai CS; Chang CC; Chuang YK; Nikolenko VN; Zotkin DA; Chiu CF; Chang JS · Biological trace element research · 2022
    Cross-sectional study150 participantsWeight Loss forChromium
  3. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  4. Prenatal Omega-3 Supplementation and Eczema Risk among Offspring at Age 36 Months.
    Berman D; Clinton C; Limb R; Somers EC; Romero V; Mozurkewich E · Insights in allergy, asthma & bronchitis · 2020
    Randomized trial84 participantsSkin Health forOmega-3
  5. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.
    Anderson RA; Cheng N; Bryden NA; Polansky MM; Cheng N; Chi J; Feng J · Diabetes · 1997
    Randomized trial180 participantsMetabolism Boost forChromium
  6. Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity.
    Masharani U; Gjerde C; McCoy S; Maddux BA; Hessler D; Goldfine ID; Youngren JF · BMC endocrine disorders · 2013
    Randomized trial31 participantsMetabolism Boost forChromium
  7. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Asemi Z · Annals of nutrition & metabolism · 2016
    Randomized trial64 participantsMetabolism Boost forChromium
  8. A Comprehensive insight into the effect of chromium supplementation on oxidative stress indices in diabetes mellitus: A systematic review.
    Kooshki F; Tutunchi H; Vajdi M; Karimi A; Niazkar HR; Shoorei H; Pourghassem Gargari B · Clinical and experimental pharmacology & physiology · 2024
    Systematic review33 studies pooledMetabolism Boost forChromium
  9. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis.
    Hu X; Wang W; Su X; Peng H; Tan Z; Li Y; Huang Y · PeerJ · 2023
    Meta-analysis2,362 participants41 studies pooledMetabolism Boost forChromium
  10. [Chromium supplementation in patients with type 2 diabetes and high risk of type 2 diabetes: a meta-analysis of randomized controlled trials].
    San Mauro-Martin I; Ruiz-León AM; Camina-Martín MA; Garicano-Vilar E; Collado-Yurrita L; Mateo-Silleras Bd; Redondo Del Río Mde P · Nutricion hospitalaria · 2017
    Meta-analysis13 studies pooledMetabolism Boost forChromium
  11. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    Liu W; Gao M; Yang S; Sun C; Bi Y; Li Y; Wang J; Yuan X · Journal of diabetes and its complications · 2023
    Meta-analysis331 participants6 studies pooledMetabolism Boost forOmega-3
  12. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
    Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L · BMJ open diabetes research & care · 2021
    Randomized trial38 participantsMetabolism Boost forOmega-3
  13. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsMetabolism Boost Skin Health forOmega-3
  14. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2018
    Randomized trial60 participantsMetabolism Boost forOmega-3
  15. A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
    Wang JF; Zhang HM; Li YY; Xia S; Wei Y; Yang L; Wang D; Ye JJ; Li HX; Yuan J; Pan RR · Lipids in health and disease · 2019
    Randomized trial200 participantsMetabolism Boost forOmega-3
  16. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  17. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  18. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3
  19. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes.
    Martin J; Wang ZQ; Zhang XH; Wachtel D; Volaufova J; Matthews DE; Cefalu WT · Diabetes care · 2006
    Randomized trial37 participantsWeight Loss forChromium
  20. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial.
    Ashoush S; Abou-Gamrah A; Bayoumy H; Othman N · The journal of obstetrics and gynaecology research · 2017
    Randomized trial100 participantsWeight Loss forChromium
  21. Chromium supplementation and polycystic ovary syndrome: A systematic review and meta-analysis.
    Fazelian S; Rouhani MH; Bank SS; Amani R · Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2018
    Meta-analysis351 participants7 studies pooledWeight Loss forChromium
  22. Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.
    Kooshki F; Moradi F; Karimi A; Niazkar HR; Khoshbaten M; Maleki V; Pourghassem Gargari B · European journal of gastroenterology & hepatology · 2021
    Randomized trial46 participantsWeight Loss forChromium